CYP19A1 and breast carcinoma: Amaral et al. [69] studied autophagy as a possible strategy for overcoming Exemestane-acquired resistance using long term estrogen deprived, aromatase overexpressing ER+ MCF-7 breast cancer cells (LTEDaro ER+) which mimic late-stage acquired resistance to AIs in patients.